IBM and New York Genome Center to collaborate using Watson technology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

IBM and the New York Genome Center will collaborate on a comprehensive and open repository of genetic data to accelerate cancer research, using Watson technology. The collaboration was announced at the White House’s Precision Medicine Initiative Summit. IBM and the center will build the capacity to house the contributed data, train Watson’s cognitive computing capabilities...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Members of the National Cancer Advisory Board’s ad hoc Working Group on Extramural Research Concepts and Programs at a recent meeting struggled to define the new group’s the role and raised concerns about some initial growing pains.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login